Puri Shailja, Asotra Sarita
Consultant Pathologist, Department of Pathology, SRL Ltd Shimla HP, Shimla, Himachal Pradesh, India.
Department of Pathology, IGMC, Shimla, Himachal Pradesh, India.
J Cancer Res Ther. 2019 Oct-Dec;15(6):1392-1394. doi: 10.4103/jcrt.JCRT_893_15.
Primary vaginal malignant melanoma (PVMM) is an extremely rare tumor of the female genital tract, accounting for only 3% of melanomas of the female genital tract and 0.3%-0.8% of all melanomas in females. Vaginal melanoma is a very aggressive tumor with a 5-year survival rate of 5%-25%. High incidence of recurrence, spread to regional lymph nodes, and distant metastasis are responsible for poor prognosis of PVMM. Grossly, amelanotic melanoma of the vagina may be mistaken for other primary vaginal malignancies. Differentiation of malignant melanoma from other primary vaginal melanomas is essential because of better prognosis of most of other vaginal malignancies as compared to melanoma. Despite having poor prognosis, early detection and early treatment of PVMM may improve the prognosis.
原发性阴道恶性黑色素瘤(PVMM)是女性生殖道极为罕见的肿瘤,仅占女性生殖道黑色素瘤的3%,占女性所有黑色素瘤的0.3%-0.8%。阴道黑色素瘤是一种侵袭性很强的肿瘤,5年生存率为5%-25%。复发率高、扩散至区域淋巴结以及远处转移是导致PVMM预后不良的原因。大体上,阴道无色素性黑色素瘤可能会被误诊为其他原发性阴道恶性肿瘤。将恶性黑色素瘤与其他原发性阴道肿瘤区分开来至关重要,因为与黑色素瘤相比,大多数其他阴道恶性肿瘤的预后较好。尽管PVMM预后较差,但早期发现和早期治疗可能会改善预后。